Block listing Interim Review
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
(Note: Italicised terms have the same meaning as given in the Listing Rules.)
Date: 31st March 2020
Name of applicant: | Circassia Pharmaceuticals plc | |||
Name of scheme: | Circassia EMI Share Option Scheme | |||
Period of return: | From: | 1st October 2019 | To: | 31st March 2020 |
Balance of unallotted securities under scheme(s) from previous return: | 700,750 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | - | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | - | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 700,750 | |||
Name of applicant: | Circassia Pharmaceuticals plc | |||
Name of scheme: | Circassia 2007 Unapproved Share Scheme | |||
Period of return: | From: | 1st October 2019 | To: | 31st March 2020 |
Balance of unallotted securities under scheme(s) from previous return: | 203,000 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | - | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | - | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 203,000 | |||
Name of applicant: | Circassia Pharmaceuticals plc | |||
Name of scheme: | Circassia 2014 Performance Share Plan Scheme | |||
Period of return: | From: | 1st October 2019 | To: | 31st March 2020 |
Balance of unallotted securities under scheme(s) from previous return: | 76,676 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | - | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | - | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 76,676 | |||
Name of applicant: | Circassia Pharmaceuticals plc | |||
Name of scheme: | Circassia 2015 Performance Share Plan Scheme | |||
Period of return: | From: | 1st October 2019 | To: | 31st March 2020 |
Balance of unallotted securities under scheme(s) from previous return: | 280,612 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | - | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | (4,442) | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 276,170 | |||
Name of applicant: | Circassia Pharmaceuticals plc | |||
Name of scheme: | Circassia 2016 Performance Share Plan Scheme | |||
Period of return: | From: | 1st October 2019 | To: | 31st March 2020 |
Balance of unallotted securities under scheme(s) from previous return: | 812,071 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | - | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | (26,902) | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 785,169 | |||
Name of contact: | Michael Roller |
Telephone number of contact: | 01865 405 560 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.